Home/Oxford Nanopore/Dr. Gordon Sanghera

DG

Dr. Gordon Sanghera

Chief Executive Officer

Oxford Nanopore

Therapeutic Areas

Oncology Infectious Disease Genetic Disease

Oxford Nanopore Pipeline

Drug	Indication	Phase
Hereditary Cancer Panel	Hereditary Cancer Risk	RUO/Clinical Research
Amplicon Barcoding Workflow	Microbial Identification	RUO
AmPORE-TB	Tuberculosis Diagnosis	IVD/CE-Marked

Leadership Team at Oxford Nanopore

Dr. Spike Willcocks

Chief Business Officer

Dr. Clive G. Brown

Chief Technology Officer

Chief Financial Officer

Professor Hagan Bayley

Professor David Deamer

View full Oxford Nanopore profile